Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-dose intra-articular triamcinolone for knee arthritis
NL-OMON34658Phase 4Active, not recruiting
- Sponsor
- Ziekenhuisgroep Twente
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of triamcinolone acetonide in arthritis and rheumatoid arthritis (RA) (2 arms), sponsored by Ziekenhuisgroep Twente. Primary endpoint: Percentage of patients with sustained good response. Started May 2010; status: active, not recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
arthritisrheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON34658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34658.